Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-24-030096

Options or other derivatives

  • Director acquired 61,192 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Zhao Baiteng Director 2024-12-19 Grant or award · Stock Option (right to buy) +61,192 61,192 D
Loading xslF345X05/form4-12232024_101210.xml…